Clearmind Medicine Inc. Quarterly Research And Development Expense in USD from Q1 2022 to Q4 2023

Taxonomy & unit
ifrs-full: CAD and USD
Summary
Clearmind Medicine Inc. quarterly/annual Research And Development Expense history and growth rate from Q1 2022 to Q4 2023.
  • Clearmind Medicine Inc. Research And Development Expense for the quarter ending January 31, 2024 was $227K, a 61.3% decline year-over-year.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2023 was $1.54M, a 49.9% decline from 2022.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2022 was $3.08M, a 550% increase from 2021.
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $227K -$360K -61.3% Nov 1, 2023 Jan 31, 2024 6-K 2024-03-19
Q1 2023 $318K -$843K -72.6% Feb 1, 2023 Apr 30, 2023 6-K 2023-06-14
Q4 2022 $588K Nov 1, 2022 Jan 31, 2023 6-K 2024-03-19
Q1 2022 $1.16M Feb 1, 2022 Apr 30, 2022 6-K 2023-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.